← All trials
NCT02577120
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 9, 2019
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2023
- First posted
- Oct 16, 2015
- Last posted
- May 15, 2023
- Enrollment
- 265
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Indiana UniversityLead sponsor
- Indiana UniversityOverall official - principal investigator
- Indiana UniversityReponsible party - principal investigator
- National Institute of Nursing Research (NINR)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.